Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT07239102
Eligibility Criteria:
Inclusion Criteria:
1. Histologically or cytologically confirmed stage IIIb-IVb NSCLC or postoperative recurrent NSCLC;
2. Positive EGFR test result, which can be determined by methods such as RT-PCR/FISH/IHC/NGS from hospital laboratories or testing institutions;
3. Patients aged ≥18 years;
4. Patients have clinically received Firmonertinib treatment, with recorded objective efficacy evaluation and adverse reactions;
5. Sign the Beijing Tiantan Hospital broad informed consent form.
Exclusion Criteria:
\- Patients who cannot provide follow-up data for at least one cycle.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07239102
Study Brief:
Protocol Section:
NCT07239102